Accustem SciencesACUT +21.61%27 Market Cap is $3.04 Mil as of Jul. 10, 2026. GuruFocus rates ACUT with a GF Score™ of 27/100. The stock has 1 warning sign investors should review. Among 1,422 Biotechnology companies, Accustem Sciences ranks worse than 95.01% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Accustem Sciences's share price for the quarter that ended in Mar. 2026 was $0.38. Accustem Sciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 16.07 Mil. Therefore, Accustem Sciences's market cap for the quarter that ended in Mar. 2026 was $6.11 Mil.
Accustem Sciences's quarterly market cap
declined
from Sep. 2025 ($27.16 Mil) to Dec. 2025 ($13.07 Mil) and
declined
from Dec. 2025 ($13.07 Mil) to Mar. 2026 ($6.11 Mil).
Accustem Sciences's annual market cap
declined
from Dec. 2023 ($7.10 Mil) to Dec. 2024 ($5.42 Mil) but then
increased
from Dec. 2024 ($5.42 Mil) to Dec. 2025 ($13.07 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Accustem Sciences's Enterprise Value for Today is $3.05 Mil.
Accustem Sciences (OTCPK:ACUT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Accustem Sciences Market Cap Related Terms
Accustem Sciences Market Cap Historical Data
* Premium members only.
The historical data trend for Accustem Sciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Accustem Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accustem Sciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Accustem Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Accustem Sciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Accustem Sciences's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accustem Sciences (ACUT) has a Market Cap of $3.04 Mil as of Jul. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Accustem Sciences and its competitors. According to the industry distribution chart, Accustem Sciences ranks #1351 out of 1422 companies in the Biotechnology industry, placing it in the top 95%.
Is Accustem Sciences' Market Cap too high?
Accustem Sciences' current Market Cap is $3.04 Mil. The Biotechnology industry median Market Cap is 120.54. Accustem Sciences' value of $3.04 Mil is 97.5% below this industry median. Based on the distribution chart, Accustem Sciences ranks #1351 out of 1422 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Accustem Sciences has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Accustem Sciences' Market Cap compare to DCOY and BIXT?
According to the Biotechnology industry distribution chart, Accustem Sciences ranks #1351 out of 1422 companies for Market Cap. This places Accustem Sciences in the lower half of its industry. The industry median Market Cap is 120.54. Accustem Sciences' value of $3.04 Mil is 97.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 120.54, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accustem Sciences's current Market Cap of $3.04 Mil is 97.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Accustem Sciences and its competitors. For the Biotechnology industry, the median Market Cap is 120.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accustem Sciences's current Market Cap is $3.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accustem Sciences stock overvalued right now?
Accustem Sciences (ACUT) has a current Market Cap of $3.04 Mil. The current Market Cap is $3.04 Mil and 97.5% below the Biotechnology industry median of 120.54. Accustem Sciences' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Accustem Sciences (ACUT), the current Market Cap is $3.04 Mil as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accustem Sciences Inc is a clinical stage diagnostics company dedicated to improving quality of life and outcomes for the millions of people who are diagnosed with cancer each year. The company's product, StemPrintER, is a genomic platform for predicting distant recurrence risk in luminal, ER+/HER2-negative breast cancer patients. Additionally, It offers ancillary commodity testing to provide further insights. Validated in various retrospective cohorts, StemPrintER shows promise for oncology clinics. Revenue is generated through product commercialization and testing services.
27GF Score
Get the complete analysis for ACUT
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACUT has been successfully added to your 
